Efficacy of cultured epidermal autograft in the treatment of vitiligo, refractory scar and refractory skin ulcer. - Efficacy of cultured epidermal autograft for skin disease

Toriyama Kazuhiro0 个研究点目标入组 60 人开始时间: 2020年3月2日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•(1) The person who has vitiligo, refractory scar and refractory skin ulcer more than six months
•(2) The person who understand and consent this clinical trial. The necessity of written consent by legal representatives (parents, guardians) as well as by the principal when the person is restricted in the age (from 16 to 20). Additionally, The necessity of written consent by legal representatives (parents, guardians) when the person is under 16 year od age.
•(3) Negative in the prescribed infection inspection (hepatitis B, hepatitis C, syphilis, human immunodeficincy virus, adult T cell leukemia)

•(1) Allergy to antibiotic (penicillin, kanamycin, streptomycin, amphotericin B), medical history of allergy to penicillins and aminoglycoside.
•(2) Allergy to animals (cow, mouse, pig)
•(3) Suspected , present illness and medical history of skin malignant tumor
•(4) Difficulty of participation due to mental disorder
•(5) Pregnant, lactating woman and possibility of pregnancy
•(6) Skin Infectious disease requiring systemic medical treatment
•(7) Positive in the prescribed infection inspection (hepatitis B, hepatitis C, syphilis, human immunodeficincy virus, adult T cell leukemia)
•(8) Not suitable for this clinical trial from the view oint of the doctors who perform regenerative medicine

发起方

Toriyama Kazuhiro